Inpatient Glycemic Control

ADA Inpatient Glycemic Control

AAAAI & ACAAI GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/61552

Contents of this Issue

Navigation

Page 4 of 11

Table 6. Criteria for the Diagnosis of Diabetes Test Comments (at least one of these tests) A1c ≥ 6.5% FPG ≥ 126 mg/dL (7.0 mmol/L) 2-h plasma glucose ≥ 200 mg/dL (11.1 mmol/L) during an OGTT Random plasma glucose ≥ 200 mg/dL (11.1 mmol/L) The test should be performed in a laboratory using a method that is National Glycohemoglobin Standardization Program (NGSP) certified and standardized to the Diabetes Control and Complications Trial (DCCT) assay.a Fasting is defined as no caloric intake for at least 8 h.a The test should be performed as described by the World Health Organization, using a glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water.a In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis.a a In the absence of unequivocal hyperglycemia, result should be confirmed by repeat testing. Table 7. Correlation of A1c with Average Glucose Mean Plasma Glucose A1c (%) 6 7 8 9 10 11 12 mg/dL 126 154 183 212 240 269 298 mmol/L 7.0 8.6 10.2 11.8 13.4 14.9 16.5 3

Articles in this issue

Archives of this issue

view archives of Inpatient Glycemic Control - ADA Inpatient Glycemic Control